Finanzwire Finanzwire
Basculer en Français
10336 Companies
214540 Keywords
144364 Articles
113636 Press releases
Headlines Articles Press releases Kedrion Remove
  1. Home
  2. Companies
  3. Kedrion
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/27/2025 at 10:10, 5 months 4 days ago

    EMA Grants Orphan Drug Designation to Kedrion's Treatment for ACP

    Biopharmaceutical Innovation Kedrion Orphan Drug EMA Approval Iron Metabolism
  • PRESS RELEASE

    published on 11/27/2025 at 10:05, 5 months 4 days ago

    European Medicines Agency (EMA) grants Orphan Drug Designation to Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia, a rare genetic disorder of iron metabolism

    Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia granted Orphan Drug Designation by EMA, highlighting commitment to rare disease innovation
    Orphan Drug Designation Rare Disease Kedrion Plasma-derived Treatment Congenital Aceruloplasminemia
    Logo of Kedrion
  • BRIEF

    published on 11/06/2025 at 14:50, 5 months 25 days ago

    Kedrion Highlights Secondary Immunodeficiencies at IPIC 2025

    Kedrion Biopharma Hematologic Malignancies Secondary Immunodeficiencies IPIC 2025 Immunoglobulin Therapy
  • PRESS RELEASE

    published on 11/06/2025 at 14:45, 5 months 25 days ago

    Secondary Immunodeficiencies in the spotlight at IPIC 2025: Kedrion champions innovation and patient care

    Kedrion Biopharma shines spotlight on Secondary Immunodeficiencies at IPIC 2025, highlighting challenges and advances in patient care
    Innovation Patient Care Kedrion Biopharma Secondary Immunodeficiencies IPIC 2025
    Logo of Kedrion
Accesswire
  • Published on 05/01/2026 at 22:30, 20 minutes ago

    Nextech3D.ai Appoints New Independent Auditor

  • Published on 05/01/2026 at 22:30, 20 minutes ago

    Integrated Rewards Achieves SOC 2 Compliance to Support Enterprise-Scale Growth Across Canada's Card-Linked Rewards Network as EQ Closes Convertible Debt Financing

  • Published on 05/01/2026 at 22:30, 20 minutes ago

    Apex Critical Metals Announces Extension of Marketing Agreement with Rumble Strip Media Inc.

  • Published on 05/01/2026 at 18:00, 4 hours 50 minutes ago

    Star Copper to Present at the Emerging Growth Conference on May 7, 2026

  • Published on 05/01/2026 at 15:35, 7 hours 15 minutes ago

    LNG Energy Group Announces Partial Revocation of Cease Trade Order and Proposed Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 05/01/2026 at 19:23, 3 hours 27 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 05/01/2026 at 18:40, 4 hours 10 minutes ago

    Holding(s) in Company

  • Published on 05/01/2026 at 17:47, 5 hours 3 minutes ago

    Key Figures 30.04.2026

  • Published on 05/01/2026 at 17:45, 5 hours 5 minutes ago

    Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)

  • Published on 05/01/2026 at 17:21, 5 hours 29 minutes ago

    Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS
Les Echos
  • Published on 04/30/2026 at 20:00, 1 day 2 hours ago

    AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue

  • Published on 04/30/2026 at 19:16, 1 day 3 hours ago

    AXA announces the results of its Shareholders' Meeting

  • Published on 04/30/2026 at 19:00, 1 day 3 hours ago

    Capital increase through exercise of subscription rights

  • Published on 04/30/2026 at 18:10, 1 day 4 hours ago

    Minutes of the Combined General Meeting held on April 30, 2026

  • Published on 04/30/2026 at 18:00, 1 day 4 hours ago

    TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy